These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12550738)

  • 1. Pharmacology of traumatic brain injury.
    Royo NC; Shimizu S; Schouten JW; Stover JF; McIntosh TK
    Curr Opin Pharmacol; 2003 Feb; 3(1):27-32. PubMed ID: 12550738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection targets after traumatic brain injury.
    Wang KK; Larner SF; Robinson G; Hayes RL
    Curr Opin Neurol; 2006 Dec; 19(6):514-9. PubMed ID: 17102687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
    Ikonomidou C; Turski L
    Lancet Neurol; 2002 Oct; 1(6):383-6. PubMed ID: 12849400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.
    Yi JH; Hazell AS
    Neurochem Int; 2006 Apr; 48(5):394-403. PubMed ID: 16473439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment and neuroprotection in traumatic brain injury.
    Clausen T; Bullock R
    Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels.
    Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE
    J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids as neuroprotective agents in traumatic brain injury.
    Biegon A
    Curr Pharm Des; 2004; 10(18):2177-83. PubMed ID: 15281893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system resuscitation.
    McIntosh TK; Garde E; Saatman KE; Smith DH
    Emerg Med Clin North Am; 1997 Aug; 15(3):527-50. PubMed ID: 9255131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacological treatment strategies in traumatic brain injury.
    Marklund N; Bakshi A; Castelbuono DJ; Conte V; McIntosh TK
    Curr Pharm Des; 2006; 12(13):1645-80. PubMed ID: 16729876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review.
    Zauner A; Bullock R
    J Neurotrauma; 1995 Aug; 12(4):547-54. PubMed ID: 8683605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and brain injury: therapeutic implications.
    Mechoulam R; Panikashvili D; Shohami E
    Trends Mol Med; 2002 Feb; 8(2):58-61. PubMed ID: 11815270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial.
    Morris GF; Juul N; Marshall SB; Benedict B; Marshall LF
    Neurosurgery; 1998 Dec; 43(6):1369-72; discussion 1372-4. PubMed ID: 9848851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of traumatic brain injury: a review of agents in development.
    Hatton J
    CNS Drugs; 2001; 15(7):553-81. PubMed ID: 11510625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of traumatic brain injury: where is the "golden bullet"?
    Beauchamp K; Mutlak H; Smith WR; Shohami E; Stahel PF
    Mol Med; 2008; 14(11-12):731-40. PubMed ID: 18769636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury.
    Sahuquillo J; Vilalta A
    Curr Pharm Des; 2007; 13(22):2310-22. PubMed ID: 17692002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurochemical changes and current pharmacological approaches in craniocerebral trauma].
    Kossmann T; Lenzlinger PM; Stover JF; Stocker R; Morganti-Kossmann MC; Trentz O
    Unfallchirurg; 1997 Aug; 100(8):613-22. PubMed ID: 9381209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998.
    McIntosh TK; Juhler M; Wieloch T
    J Neurotrauma; 1998 Oct; 15(10):731-69. PubMed ID: 9814632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic brain injury: can the consequences be stopped?
    Park E; Bell JD; Baker AJ
    CMAJ; 2008 Apr; 178(9):1163-70. PubMed ID: 18427091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
    Muir KW
    Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.